Suppliers / Nang Kuang Pharmaceutical

Nang Kuang Pharmaceutical

Taiwan Updated 9 July 2026

Nang Kuang Pharmaceutical is a finished-dose manufacturer based in Taiwan. It appears in 16 regulatory filings across 4 regulators, without an active US DMF or CEP on file. Its filings concentrate with NPRA (MY), US FDA and NMPA (CN). Its most recent recorded inspection, by US FDA, closed on 2 April 2024 as OAI.

0
active US DMFs
0
valid CEPs
1
registered plants 1 with an FDA FEI number
16
filings across 4 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
5 of 5 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 2 April 2024 OAI US FDA
  • 6 November 2018 VAI US FDA
  • 5 September 2017 VAI US FDA
  • 24 April 2015 VAI US FDA
  • 30 August 2013 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Taiwan, Taiwan 3004396086

Filings and GMP by regulator

Regulator Filings GMP certificates
NPRA (MY) 6 None
US FDA 5 None
NMPA (CN) 4 None
ARCSA (EC) 1 None

Questions about Nang Kuang Pharmaceutical

Does Nang Kuang Pharmaceutical hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Nang Kuang Pharmaceutical. It does have 16 filings with 4 regulators, so it is registered, just not with the two strong registers buyers usually screen on.
Is Nang Kuang Pharmaceutical FDA-registered?
One site operated by Nang Kuang Pharmaceutical carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Nang Kuang Pharmaceutical's last inspection go?
The most recent inspection on record closed on 2 April 2024 as OAI (Official Action Indicated, the worst classification: objectionable conditions were found and regulatory action was warranted). 5 inspections are on file, of which 1 closed as OAI.
Where does Nang Kuang Pharmaceutical manufacture?
1 registered site is on record, in Taiwan (Taiwan). Every site is listed on this page with the register it came from.
Where does Nang Kuang Pharmaceutical file?
Filings are on record with NPRA (MY), US FDA, NMPA (CN) and ARCSA (EC), 16 in total.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Nang Kuang Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was OAI, on 2 April 2024.

Comparable suppliers

Bora Pharmaceutical Laboratories also in Taiwan Bora Pharmaceuticals also in Taiwan Lotus Pharmaceutical Co Ltd Nantou Plant also in Taiwan Lotus Pharmaceutical also in Taiwan Tty Biopharm also in Taiwan

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability